Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in ...
A judge on Tuesday rejected a challenge from major pharmaceutical companies against Washington’s new law trying to reduce ...
Eli Lilly begins denying 340B discounts to hospitals that fail to submit required claims-level data under its reporting rules.
Jean Jethro Alexandre faces federal prison after weaponizing a safety-net drug discount program for personal enrichment.
Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the Health, Education, Labor and Pensions Committee appear to agree that ...
WASHINGTON: The U.S. Department of Health and Human Services building is shown in Washington, DC. (Photo by Mark Wilson/Getty Images) In 1992, Congress created the 340B Drug Pricing Program to provide ...
The acquisition will expand Model N’s capabilities as a leading revenue management platform for life sciences manufacturers and extend its 340B offerings to better serve customers. 340B, a federal ...
Established under the Public Health Service Act in 1992, the 340B drug pricing program has a critical goal: improve access to medicines for low-income patients at qualifying hospitals and clinics.
The 340B program was originally designed to assist hospitals that treat under- or uninsured patients in receiving discounted pharmaceutical drugs. Now, the federal subsidy program is getting a second ...
Participation in the 340B Drug Pricing Program by general acute care hospitals and critical access hospitals has not been associated with increased provision of uncompensated care. Objectives: To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results